China Shineway Pharmaceutical Group Limited

OTCPK:CSWY.Y Stock Report

Market Cap: US$788.9m

China Shineway Pharmaceutical Group Past Earnings Performance

Past criteria checks 4/6

China Shineway Pharmaceutical Group has been growing earnings at an average annual rate of 20.8%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 13.4% per year. China Shineway Pharmaceutical Group's return on equity is 15.1%, and it has net margins of 26.3%.

Key information

20.8%

Earnings growth rate

21.6%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate13.4%
Return on equity15.1%
Net Margin26.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How China Shineway Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CSWY.Y Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,2051,1052,111107
31 Mar 244,3611,0372,212109
31 Dec 234,5179702,314110
30 Sep 234,5259262,318124
30 Jun 234,5348832,323137
31 Mar 234,2428032,215127
31 Dec 223,9517232,107117
30 Sep 223,7186512,004117
30 Jun 223,4855791,902116
31 Mar 223,3545681,832115
31 Dec 213,2245571,763113
30 Sep 213,1224531,676109
30 Jun 213,0203501,590105
31 Mar 212,8383221,528102
31 Dec 202,6562951,466100
30 Sep 202,5923821,42588
30 Jun 202,5284691,38477
31 Mar 202,6174861,39390
31 Dec 192,7065031,402103
30 Sep 192,6705201,367102
30 Jun 192,6335371,332100
31 Mar 192,6025211,293114
31 Dec 182,5705061,254128
30 Sep 182,4925161,174136
30 Jun 182,4135261,095144
31 Mar 182,166489929120
31 Dec 171,92045276397
30 Sep 171,89747470881
30 Jun 171,87349665366
31 Mar 171,93354265170
31 Dec 161,99358964874
30 Sep 161,93556965979
30 Jun 161,87754966984
31 Mar 161,96660367376
31 Dec 152,05565867869
30 Sep 152,14767269173
30 Jun 152,23968570578
31 Mar 152,23469570179
31 Dec 142,22970569780
30 Sep 142,22870469779
30 Jun 142,22770369878
31 Mar 142,20769369981
31 Dec 132,18768470183

Quality Earnings: CSWY.Y has high quality earnings.

Growing Profit Margin: CSWY.Y's current net profit margins (26.3%) are higher than last year (19.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CSWY.Y's earnings have grown significantly by 20.8% per year over the past 5 years.

Accelerating Growth: CSWY.Y's earnings growth over the past year (25.1%) exceeds its 5-year average (20.8% per year).

Earnings vs Industry: CSWY.Y earnings growth over the past year (25.1%) did not outperform the Pharmaceuticals industry 54.6%.


Return on Equity

High ROE: CSWY.Y's Return on Equity (15.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies